CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 3.99: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.87BCNY426.38M · vs all stocks (USD)
Trailing P/E
372.00xRevenue (TTM)
309.53MCNY46.03M · vs all stocks (USD)
Profit Margin
1.31%Beta
0.5910xvs all stocks
52-Week Change
-56.67%vs all stocks
Market Capitalization
2.87BCNY426.38M · vs all stocks (USD)
Enterprise Value
2.92BCNY434.96M · vs all stocks (USD)
Trailing P/E
372.00xPrice to Sales (TTM)
9.31xPrice to Book (MRQ)
9.16xEnterprise to Revenue
9.45xEnterprise to EBITDA
123.14xGross Margin
30.48%Profit Margin
1.31%Operating Margin
-3.62%Return on Assets (TTM)
0.71%Return on Equity (TTM)
2.42%Revenue (TTM)
309.53MCNY46.03M · vs all stocks (USD)
Revenue per Share (TTM)
0.3960CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-6.20%Gross Profit (TTM)
90.95MCNY13.53M · vs all stocks (USD)
EBITDA (TTM)
57.04MCNY8.48M · vs all stocks (USD)
Net Income (TTM)
4.07MCNY605.29K · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-22.04%Operating Cash Flow (TTM)
57.90MCNY8.61M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
42.36MCNY6.30M · vs all stocks (USD)
5-Year Average Dividend Yield
1.23%vs all stocks
Payout Ratio
214.55%Minority Interest (Equity)
55.12MCNYFY2025 · Dec 31, 2025Revenue
314.12MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
221.55MCNYFY2025 · Dec 31, 2025Gross Profit
92.56MCNYFY2025 · Dec 31, 2025Operating Income
12.58MCNY1.87M · vs all stocks (USD)
Pre-tax Income
15.61MCNYFY2025 · Dec 31, 2025Income Tax Expense
7.02MCNYFY2025 · Dec 31, 2025Net Income
8.59MCNYFY2025 · Dec 31, 2025EBIT
25.13MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
57.04MCNYFY2025 · Dec 31, 2025Research & Development
6.43MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
30.13MCNYFY2025 · Dec 31, 2025Other Operating Expenses
6.45MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
9.53MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0045CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0045CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
776.11MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
776.11MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
8.59MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.09MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
8.54MCNYFY2025 · Dec 31, 2025Free Cash Flow
5.60MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
137.05MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
8.59MCNYFY2025 · Dec 31, 2025Other Non-cash Items
23.59MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-30.05MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
6.41MCNYFY2025 · Dec 31, 2025Capital Expenditures
-2.94MCNYFY2025 · Dec 31, 2025Sale of Investments
1.34MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.59MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
56.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-40.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-9.95MCNYFY2025 · Dec 31, 2025Other Financing Charges
-26.89MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-20.84MCNYFY2025 · Dec 31, 2025Shares Outstanding
774.92MSharesUpdated Aug 20, 2026Float Shares
358.85MSharesUpdated Aug 20, 2026% Held by Insiders
55.03%vs all stocks
% Held by Institutions
3.95%vs all stocks
Total Cash (MRQ)
143.47MCNY21.34M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1850CNYUpdated Aug 20, 2026Total Debt (MRQ)
152.67MCNY22.70M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4120xCurrent Ratio (MRQ)
1.19xBook Value per Share (MRQ)
0.4060CNYUpdated Aug 20, 2026Total Assets
748.65MCNY111.33M · vs all stocks (USD)
Total Current Assets
254.45MCNYFY2025 · Dec 31, 2025Total Liabilities
372.91MCNYFY2025 · Dec 31, 2025Total Non-current Assets
494.20MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
156.64MCNYFY2025 · Dec 31, 2025Total Current Liabilities
216.27MCNYFY2025 · Dec 31, 2025Cash
136.77MCNYFY2025 · Dec 31, 2025Cash Equivalents
305.71KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
137.07MCNYFY2025 · Dec 31, 2025Other Short-term Investments
11.45MCNYFY2025 · Dec 31, 2025Accounts Receivable
49.20MCNYFY2025 · Dec 31, 2025Inventory
36.81MCNYFY2025 · Dec 31, 2025Accounts Payable
19.88MCNYFY2025 · Dec 31, 2025Short-term Debt
54.63MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.00MCNYFY2025 · Dec 31, 2025Long-term Debt
105.69MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
4.59MCNYFY2025 · Dec 31, 2025Common Stock (Book)
774.92MCNYFY2025 · Dec 31, 2025Retained Earnings
-651.51MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
375.74MCNY55.88M · vs all stocks (USD)
52-Week Low
3.67CNYUpdated Aug 20, 202652-Week High
9.19CNYUpdated Aug 20, 202652-Week Change
-56.67%vs all stocks
Beta
0.5910xvs all stocks
50-Day MA
4.99CNYUpdated Aug 20, 2026200-Day MA
6.04CNYUpdated Aug 20, 2026Avg 10-Day Volume
10.94MSharesUpdated Aug 20, 2026Avg 30-Day Volume
11.04MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.0100CNYUpdated Aug 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Working Capital Pattern
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.99: safe zoneNotable
Altman Z-Score: 3.99
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Canopus Wisdom MedTech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hua Medicine Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Qinghai Spring Medicinal Resources Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Kehua Bio-Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Eupraxia Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tenax Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nanhua Bio-Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Canopy Growth Corporation
Tier 1ProductionApproval-Gated PipelineFlowRule
Elite Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Abclon Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
American Battery Technology Company
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWorking Capital Pattern
Abclon Inc.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWorking Capital Pattern
Apact Co. Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWorking Capital Pattern